Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03150381 · ClinicalTrials.gov registry record · NA
Promoting Weight-Loss in African American Cancer Survivors in the Deep South
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 369
- Enrollment target
NCT03150381: Completed NA study, sponsored by University of Alabama at Birmingham.
NCT03150381 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 369 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03150381, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 369 participants
- Enrollment target
Study Summary
This study tests evidence-based strategies for weight loss among overweight and obesity cancer survivors and family members in rural Alabama.
Primary Outcome
Measured weight (nearest kg)
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Weight Loss Only
- BEHAVIORAL Weight Loss Plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 369 participants |
| Start Date | 2012-05-01 |
| Est. Completion | 2018-03-31 |
| Phase | NA |
What the finished NCT03150381 record still lists
NCT03150381 is an interventional study that assigns participants to a tested intervention. The registered 369 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT03150381 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03150381 about?
NCT03150381 is a clinical study titled "Promoting Weight-Loss in African American Cancer Survivors in the Deep South". This study tests evidence-based strategies for weight loss among overweight and obesity cancer survivors and family members in rural Alabama.
What is the current status of trial NCT03150381?
This trial is currently completed. It is a NA study. The enrollment target is 369 participants. The study started on 2012-05-01. Estimated completion is 2018-03-31.
What interventions are being tested in trial NCT03150381?
The interventions under investigation include: Control (BEHAVIORAL), Weight Loss Only (BEHAVIORAL), Weight Loss Plus (BEHAVIORAL).
Who is sponsoring clinical trial NCT03150381?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03150381's enrollment target sits among peer trials
369 281st of 2000 higher than 1,718 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06114836 · 369 participants · NA
GERD Infant Feeding Therapeutics Trial (GIFT Trial)
- NCT06585410 · 369 participants · Phase 3
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
- NCT07256717 · 369 participants · NA
BPIT 5-Week Multi-Site Study: Movement Efficiency, Mobility & Neuromuscular Adaptation
- NCT02332668 · 370 participants · Phase 1
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI